Kansas City Clincal Oncology Program CCOP

描述（由申请人提供）：堪萨斯城社区临床肿瘤学项目（KCCOP）已经为堪萨斯城大都市区及其他地区的公民提供了超过25年的服务。自1983年以来，KCCOP是全国27个连续获得资助的CCOP项目之一。该项目包括一个由社区医院、医师调查员和行政支持组成的网络，为堪萨斯城地区的国家癌症研究所临床试验提供广泛的患者通道。二十多年来，KCCOP已经超过了治疗、预防和癌症控制试验的最低累积要求。KCCOP是一项由11个堪萨斯城地区卫生保健组织和50多名内科肿瘤学家、放射肿瘤学家、外科医生和其他专家参与的合作项目。该项目隶属于全国主要的研究基地，包括西南肿瘤小组、放射治疗肿瘤小组、妇科肿瘤小组、国家手术辅助乳房和肠项目、MD安德森癌症中心、癌症和白血病B组、罗切斯特大学癌症中心和国家癌症研究所临床试验支持单位。医疗保健和临床试验环境的变化需要承诺和灵活性。kcccop拥有敬业和经验丰富的员工，强有力的领导和协作精神，为不断变化的时代提供了适当的平衡。该程序监控趋势并实施持续改进的措施。KCCOP平衡了保护患者——他们的安全、健康、福祉和隐私——与通过启动试验、少数群体外联、医生参与以及反应迅速和负责任的支持人员提供尽可能广泛的途径。最近，KCCOP将重点放在低收益调查人员身上，为他们提供额外的资源。明年的目标是将癌症治疗和预防试验的积分增加到100个以上。

DESCRIPTION (provided by applicant): The Kansas City Community Clinical Oncology Program (KCCOP) has served the citizens of the Kansas City metropolitan area and beyond for more than 25 years. The KCCOP is one of 27 programs in the nation continuously funded as a CCOP since 1983. The program includes a network of community hospitals, physician investigators, and administrative support to provide broad patient access to National Cancer Institute clinical trials in the Kansas City area. For more than two decades, the KCCOP has exceeded the minimum accrual requirements for treatment, prevention, and cancer control trials. The KCCOP is a cooperative effort involving 11 Kansas City area health care organizations and over 50 medical oncologists, radiation oncologists, surgeons, and other specialists. This program is affiliated with major research bases throughout the nation including the Southwest Oncology Group, Radiation Therapy Oncology Group, Gynecologic Oncology Group, National Surgical Adjuvant Breast and Bowel Project, MD Anderson Cancer Center, Cancer & Leukemia Group B, University of Rochester Cancer Center, and the Clinical Trials Support Unit of the National Cancer Institute. Changes in the healthcare and clinical trials environment require commitment and flexibility. The KCCOP has a dedicated and experienced staff, strong leadership, and a collaborative spirit which provide the right balance for changing times. This program monitors trends and implements measures for continuous improvement. The KCCOP balances protecting patients - their safety and health, well-being, and privacy - with providing the broadest possible access through trial activation, minority outreach, physician participation, and a highly responsive and responsible support staff. Recently, the KCCOP has focused on low accruing investigators to provide them with additional resources. Goals are set to increase accrual in the next year to exceed 100 credits for both cancer treatment and prevention trials. RELEVANCE: The KCCOP supports the network mission to accelerate development of interventions to prevent and treat cancer by increasing accruals to trials, fostering quality care in the community through adoption of results, and increasing the involvement of minority and underserved patient populations in cancer clinical trials.